The proliferation and invasion of oral cancer is bolstered by tumor-infiltrating pDCs through the activation of the TNF-α/NF-κB/CXCR-4 pathway, which may serve as a potential immunological target for the treatment of OSCCs in the future [111]. The gene discussed is CXCR4; the disease is neoplasm.